Skip to main content
Clinical Trials/NCT00139984
NCT00139984
Completed
Phase 4

Impact of Ambulatory Blood Pressure Monitoring for Antihypertensive Treatment Guidance in Medical Outpatients: The Hyper-ABC Study

University Hospital, Basel, Switzerland2 sites in 1 country170 target enrollmentOctober 2003
ConditionsHypertension

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hypertension
Sponsor
University Hospital, Basel, Switzerland
Enrollment
170
Locations
2
Primary Endpoint
Change in 24-hour systolic blood pressure from baseline to 1 year
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether in patients with arterial hypertension, treatment guidance using 24-hour blood pressure measurement results in better blood pressure control compared to treatment guidance using office blood pressure measurement.

Detailed Description

Blood pressure control in arterial hypertension remains poor, despite the availability of effective drug treatment. Therefore, strategies to increase blood pressure control are urgently needed. 24 hour blood pressure is a better predictor of cardiovascular morbidity and mortality than office blood pressure. Furthermore, the lower variability of measurements over time of 24 hour blood pressure could allow better adjustment of antihypertensive therapy. However, there are only scarce data about antihypertensive treatment adjustment using 24 hour blood pressure instead of office blood pressure. Aim: To test the hypothesis that a 24 hour blood pressure guided therapy is is more effective in reaching blood pressure control when compared to conventional office blood pressure guided therapy.

Registry
clinicaltrials.gov
Start Date
October 2003
End Date
May 2007
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Uncontrolled hypertension (office BP \>139/89mmHg AND 24h BP \>129/79mmHg)

Exclusion Criteria

  • Severe concomitant illness including heart failure, significant valvular heart disease or malignancy

Outcomes

Primary Outcomes

Change in 24-hour systolic blood pressure from baseline to 1 year

Secondary Outcomes

  • Change in 24-hour diastolic blood pressure from baseline to 1 year
  • Primary outcome measure in patients with treated hypertension at baseline

Study Sites (2)

Loading locations...

Similar Trials